Anika Therapeutics Earnings Conference Call (Q2 2012) Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other Aug 2 Calls
Today's Calls
Call Details
Anika Therapeutics Earnings Conference Call (Q2 2012)
Scheduled to start Thu, Aug 2, 2012, 9:00 am Eastern

-- this event is ongoing now--
Listen to the ongoing live event audio stream

About Anika Therapeutics Inc (NasdaqGS:ANIK)Other Calls 
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company offers ORTHOVISC, which is used for the treatment of osteoarthritis in knees and various joints; ORTHOVISC mini that is used for the treatment of osteoarthritis in small joints; and MONOVISC, a single injection product used for the treatment of osteoarthritis in various joints. It also provides wound care products that comprise Hyalograft 3D used for the regeneration of skin; and Hyalomatrix used for the treatment of burns and ulcers. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, and ShellGel, which are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides INCERT, a HA based product used for the prevention of post-surgical adhesions; Hyalobarrier and Hyalobarrier Endo, which are post operative adhesion barriers for abdominal indications; and HYVISC, an HA product used for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis. Additionally, the company offers Merogel, a product used for the treatment of ear, nose, and throat disorders. It also provides products for facial wrinkles and scar remediation under the HYDRELLE and ELEVESS brand names. Anika Therapeutics, Inc. sells its products directly, as well as through a network of distributors primarily in the United States, Europe, and Turkey. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings

Copyright © 2012 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2012 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.